Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 104

Similar articles for PubMed (Select 19720928)

1.

Impact of micrometastases in the sentinel node of patients with invasive breast cancer.

Hansen NM, Grube B, Ye X, Turner RR, Brenner RJ, Sim MS, Giuliano AE.

J Clin Oncol. 2009 Oct 1;27(28):4679-84. doi: 10.1200/JCO.2008.19.0686. Epub 2009 Aug 31.

2.

Biological significance of occult micrometastases in histologically negative axillary lymph nodes in breast cancer patients using the recent American Joint Committee on Cancer breast cancer staging system.

Kahn HJ, Hanna WM, Chapman JA, Trudeau ME, Lickley HL, Mobbs BG, Murray D, Pritchard KI, Sawka CA, McCready DR, Marks A.

Breast J. 2006 Jul-Aug;12(4):294-301.

PMID:
16848838
3.

Impact and outcomes of routine microstaging of sentinel lymph nodes in breast cancer: significance of the pN0(i+) and pN1mi categories.

Pugliese MS, Beatty JD, Tickman RJ, Allison KH, Atwood MK, Szymonifka J, Arthurs ZM, Huynh PP, Dawson JH.

Ann Surg Oncol. 2009 Jan;16(1):113-20. doi: 10.1245/s10434-008-0121-x. Epub 2008 Oct 23.

PMID:
18949520
4.

Occult axillary node metastases in breast cancer are prognostically significant: results in 368 node-negative patients with 20-year follow-up.

Tan LK, Giri D, Hummer AJ, Panageas KS, Brogi E, Norton L, Hudis C, Borgen PI, Cody HS 3rd.

J Clin Oncol. 2008 Apr 10;26(11):1803-9. doi: 10.1200/JCO.2007.12.6425. Epub 2008 Mar 10.

5.
6.
7.

Pathobiology of preoperative chemotherapy: findings from the National Surgical Adjuvant Breast and Bowel (NSABP) protocol B-18.

Fisher ER, Wang J, Bryant J, Fisher B, Mamounas E, Wolmark N.

Cancer. 2002 Aug 15;95(4):681-95.

8.

Prognostic value of sentinel lymph node biopsy in the pathologic staging of colorectal cancer patients.

Bertoglio S, Sandrucci S, Percivale P, Goss M, Gipponi M, Moresco L, Mussa B, Mussa A.

J Surg Oncol. 2004 Mar;85(3):166-70.

PMID:
14991889
9.
10.

Breast cancer survival in relation to the metastatic tumor burden in axillary lymph nodes.

Andersson Y, Frisell J, Sylvan M, de Boniface J, Bergkvist L.

J Clin Oncol. 2010 Jun 10;28(17):2868-73. doi: 10.1200/JCO.2009.24.5001. Epub 2010 May 10.

11.

Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.

Gipponi M, Bassetti C, Canavese G, Catturich A, Di Somma C, Vecchio C, Nicolò G, Schenone F, Tomei D, Cafiero F.

J Surg Oncol. 2004 Mar;85(3):102-11. Review.

PMID:
14991881
12.

Axillary dissection is not required for all patients with breast cancer and positive sentinel nodes.

Guenther JM, Hansen NM, DiFronzo LA, Giuliano AE, Collins JC, Grube BL, O'Connell TX.

Arch Surg. 2003 Jan;138(1):52-6.

PMID:
12511150
13.

An axilla scoring system to predict non-sentinel lymph node status in breast cancer patients with sentinel lymph node involvement.

Barranger E, Coutant C, Flahault A, Delpech Y, Darai E, Uzan S.

Breast Cancer Res Treat. 2005 May;91(2):113-9.

PMID:
15868438
14.

Sentinel node tumor burden according to the Rotterdam criteria is the most important prognostic factor for survival in melanoma patients: a multicenter study in 388 patients with positive sentinel nodes.

van Akkooi AC, Nowecki ZI, Voit C, Schäfer-Hesterberg G, Michej W, de Wilt JH, Rutkowski P, Verhoef C, Eggermont AM.

Ann Surg. 2008 Dec;248(6):949-55. doi: 10.1097/SLA.0b013e31818fefe0.

PMID:
19092339
15.

Omitting axillary lymph node dissection in sentinel node negative breast cancer patients is safe: a long term follow-up analysis.

Torrenga H, Fabry H, van der Sijp JR, van Diest PJ, Pijpers R, Meijer S.

J Surg Oncol. 2004 Oct 1;88(1):4-7; discussion 7-8.

PMID:
15384064
16.

Distinction between isolated tumor cells and micrometastases in breast cancer: is it reliable and useful?

de Mascarel I, MacGrogan G, Debled M, Brouste V, Mauriac L.

Cancer. 2008 Apr 15;112(8):1672-8. doi: 10.1002/cncr.23368.

17.

Clinicopathologic analysis of sentinel lymph node mapping in early breast cancer.

Choi SH, Barsky SH, Chang HR.

Breast J. 2003 May-Jun;9(3):153-62.

PMID:
12752622
18.

Minimal axillary lymph node involvement in breast cancer has different prognostic implications according to the staging procedure.

Montagna E, Viale G, Rotmensz N, Maisonneuve P, Galimberti V, Luini A, Intra M, Veronesi P, Mazzarol G, Pruneri G, Renne G, Torrisi R, Cardillo A, Cancello G, Goldhirsch A, Colleoni M.

Breast Cancer Res Treat. 2009 Nov;118(2):385-94. doi: 10.1007/s10549-009-0446-6. Epub 2009 Jun 27.

PMID:
19562480
19.

The value of intraoperative frozen section examination of sentinel lymph nodes in breast cancer.

van de Vrande S, Meijer J, Rijnders A, Klinkenbijl JH.

Eur J Surg Oncol. 2009 Mar;35(3):276-80. doi: 10.1016/j.ejso.2008.07.016. Epub 2008 Sep 10.

PMID:
18786801
20.

[Sentinel node biopsy without systematic axillary dissection: study about 1000 procedures].

Giard S, Chauvet MP, Houpeau JL, Baranzelli MC, Carpentier P, Fournier C, Belkacemi Y, Bonneterre J.

Gynecol Obstet Fertil. 2005 Apr;33(4):213-9. Epub 2005 Apr 7. French.

PMID:
15894205
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk